de Bie RMA - Search Results

1

Value of Clinical Signs in Identifying Patients with Scans without Evidence of Dopaminergic Deficit (SWEDD).

Suwijn SR, Samim H, Eggers C, Espay AJ, Fox S, Lang AE, Samuel M, Silverdale M, Verschuur CVM, Dijk JM, Verberne HJ, Booij J, de Bie RMA. Suwijn SR, et al. Among authors: de bie rma. J Parkinsons Dis. 2020;10(4):1561-1569. doi: 10.3233/JPD-202090. J Parkinsons Dis. 2020. PMID: 32597819 Free PMC article. Clinical Trial.

2

Clinical practice regarding dopamine-agonist use and driving in Parkinson's disease.

de Bie RM, Miyasaki J, Lang AE, Fox SH. de Bie RM, et al. Can J Neurol Sci. 2007 Nov;34(4):438-42. doi: 10.1017/s0317167100007320. Can J Neurol Sci. 2007. PMID: 18062452

3

[Early treatment of Parkinson's disease with levodopa].

Odekerken VJ, Post B, Verschuur CV, de Bie RM. Odekerken VJ, et al. Ned Tijdschr Geneeskd. 2009;153:A286. Ned Tijdschr Geneeskd. 2009. PMID: 19785822 Dutch.

4

SERT-to-DAT ratios in early Parkinson's disease do not correlate with the development of dyskinesias.

Suwijn SR, Berendse HW, Verschuur CV, Winogrodzka A, de Bie RM, Booij J. Suwijn SR, et al. EJNMMI Res. 2013 Jun 5;3(1):44. doi: 10.1186/2191-219X-3-44. EJNMMI Res. 2013. PMID: 23738774 Free PMC article.

5

The role of SPECT imaging of the dopaminergic system in translational research on Parkinson's disease.

Suwijn SR, de Bruin K, de Bie RM, Booij J. Suwijn SR, et al. Parkinsonism Relat Disord. 2014 Jan;20 Suppl 1:S184-6. doi: 10.1016/S1353-8020(13)70043-9. Parkinsonism Relat Disord. 2014. PMID: 24262177 Review.

6

Parkinson's disease mild cognitive impairment: application and validation of the criteria.

Geurtsen GJ, Hoogland J, Goldman JG, Schmand BA, Tröster AI, Burn DJ, Litvan I; MDS Study Group on the Validation of PD-MCI Criteria. Geurtsen GJ, et al. J Parkinsons Dis. 2014;4(2):131-7. doi: 10.3233/JPD-130304. J Parkinsons Dis. 2014. PMID: 24296865 Free PMC article. Review.

7

Serotonin transporter availability in early stage Parkinson's disease and multiple system atrophy.

Suwijn SR, Berendse HW, Verschuur CV, de Bie RM, Booij J. Suwijn SR, et al. ISRN Neurol. 2014 Feb 3;2014:345132. doi: 10.1155/2014/345132. eCollection 2014. ISRN Neurol. 2014. PMID: 24693450 Free PMC article.

8

The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson's disease or clinically uncertain parkinsonism: a systematic review.

Suwijn SR, van Boheemen CJ, de Haan RJ, Tissingh G, Booij J, de Bie RM. Suwijn SR, et al. EJNMMI Res. 2015 Mar 17;5:12. doi: 10.1186/s13550-015-0087-1. eCollection 2015. EJNMMI Res. 2015. PMID: 25853018 Free PMC article.

9

Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson's disease: the LEAP-study.

Verschuur CV, Suwijn SR, Post B, Dijkgraaf M, Bloem BR, van Hilten JJ, van Laar T, Tissingh G, Deuschl G, Lang AE, de Haan RJ, de Bie RM. Verschuur CV, et al. BMC Neurol. 2015 Nov 19;15:236. doi: 10.1186/s12883-015-0491-1. BMC Neurol. 2015. PMID: 26584951 Free PMC article. Clinical Trial.

10

Substituting the Target After Unsatisfactory Outcome of Deep Brain Stimulation in Advanced Parkinson's Disease: Cases From the NSTAPS Trial and Systematic Review of the Literature.

Ten Brinke TR, Odekerken VJJ, van Laar T, van Dijk JMC, Dijk JM, van den Munckhof P, Schuurman PR, de Bie RMA. Ten Brinke TR, et al. Among authors: de bie rma. Neuromodulation. 2018 Aug;21(6):527-531. doi: 10.1111/ner.12732. Epub 2017 Nov 22. Neuromodulation. 2018. PMID: 29164735

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

191 results

Search Page